EKSO logo

Ekso Bionics Holdings (EKSO) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 January 2014

Indexes:

Not included

Description:

Ekso Bionics Holdings develops advanced robotic exoskeletons to assist individuals with mobility challenges. Their technology aims to improve rehabilitation for patients with spinal cord injuries and other conditions, enhancing movement and independence. The company focuses on innovation in wearable robotics for medical and industrial applications.

Events Calendar

Earnings

Next earnings date:

Mar 04, 2025

Recent quarterly earnings:

Oct 28, 2024

Recent annual earnings:

Mar 04, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 25, 2020

Analyst ratings

Recent major analysts updates

29 Oct '24 Lake Street
Buy
29 Oct '24 HC Wainwright & Co.
Buy
30 July '24 HC Wainwright & Co.
Buy
24 June '24 Lake Street
Buy
30 Apr '24 HC Wainwright & Co.
Buy
05 Mar '24 HC Wainwright & Co.
Buy
22 Jan '24 HC Wainwright & Co.
Buy
28 Apr '23 HC Wainwright & Co.
Buy
30 Mar '23 HC Wainwright & Co.
Buy
29 July '22 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19
Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19
Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19
EKSO
globenewswire.com18 November 2024

SAN RAFAEL, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Katherine Strausser, Principal Controls Engineer at Ekso Bionics, will be participating in an ‘AI for Good' webinar.

Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
EKSO
globenewswire.com12 November 2024

SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, Chief Executive Officer, and Jerome Wong, Chief Financial Officer, will be participating at the 15th Annual Craig-Hallum Alpha Select Conference taking place in New York on Tuesday, November 19, 2024.

Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates
Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates
Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates
EKSO
zacks.com28 October 2024

Ekso Bionics (EKSO) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.24 per share a year ago.

Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript
EKSO
seekingalpha.com28 October 2024

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wong - Chief Financial Officer Conference Call Participants Ben Haynor - Lake Street Capital Markets Swayampakula Ramakanth - H.C. Wainwright Operator Greetings, and welcome to the Ekso Bionics Quarter Three 2024 Financial Results Call.

Ekso Bionics Announces Third Quarter 2024 Financial Results
Ekso Bionics Announces Third Quarter 2024 Financial Results
Ekso Bionics Announces Third Quarter 2024 Financial Results
EKSO
globenewswire.com28 October 2024

SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended September 30, 2024.

Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024
Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024
Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024
EKSO
globenewswire.com21 October 2024

SAN RAFAEL, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2024 after the close of trading on Monday, October 28, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update
Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update
Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update
EKSO
zacks.com26 August 2024

Ekso Bionics EKSO has reached a significant milestone in terms of transforming mobility solutions, particularly for individuals with spinal cord injuries (SCI). The company recently secured initial reimbursement from the Centers for Medicare & Medicaid Services (CMS) for its Ekso Indego Personal exoskeleton.

Why Is Ekso Bionics (EKSO) Stock Down 15% Today?
Why Is Ekso Bionics (EKSO) Stock Down 15% Today?
Why Is Ekso Bionics (EKSO) Stock Down 15% Today?
EKSO
investorplace.com30 July 2024

Ekso Bionics (NASDAQ: EKSO ) stock is taking a beating on Tuesday following the release of the exoskeleton company's Q2 earnings report. The bad news for Ekso Bionics starts with its diluted earnings per share of -13 cents.

Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024
Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024
Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024
EKSO
globenewswire.com29 July 2024

SAN RAFAEL, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and six months ended June 30, 2024.

Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
EKSO
globenewswire.com22 July 2024

SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2024 after the close of trading on Monday, July 29, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

  • 1(current)
  • 2
  • 3
  • 1(current)
  • 2
  • 3

FAQ

  • What is the primary business of Ekso Bionics Holdings?
  • What is the ticker symbol for Ekso Bionics Holdings?
  • Does Ekso Bionics Holdings pay dividends?
  • What sector is Ekso Bionics Holdings in?
  • What industry is Ekso Bionics Holdings in?
  • What country is Ekso Bionics Holdings based in?
  • When did Ekso Bionics Holdings go public?
  • Is Ekso Bionics Holdings in the S&P 500?
  • Is Ekso Bionics Holdings in the NASDAQ 100?
  • Is Ekso Bionics Holdings in the Dow Jones?
  • When was Ekso Bionics Holdings's last earnings report?
  • When does Ekso Bionics Holdings report earnings?
  • Should I buy Ekso Bionics Holdings stock now?

What is the primary business of Ekso Bionics Holdings?

Ekso Bionics Holdings develops advanced robotic exoskeletons to assist individuals with mobility challenges. Their technology aims to improve rehabilitation for patients with spinal cord injuries and other conditions, enhancing movement and independence. The company focuses on innovation in wearable robotics for medical and industrial applications.

What is the ticker symbol for Ekso Bionics Holdings?

The ticker symbol for Ekso Bionics Holdings is NASDAQ:EKSO

Does Ekso Bionics Holdings pay dividends?

No, Ekso Bionics Holdings does not pay dividends

What sector is Ekso Bionics Holdings in?

Ekso Bionics Holdings is in the Healthcare sector

What industry is Ekso Bionics Holdings in?

Ekso Bionics Holdings is in the Medical Instruments & Supplies industry

What country is Ekso Bionics Holdings based in?

Ekso Bionics Holdings is headquartered in United States

When did Ekso Bionics Holdings go public?

Ekso Bionics Holdings's initial public offering (IPO) was on 17 January 2014

Is Ekso Bionics Holdings in the S&P 500?

No, Ekso Bionics Holdings is not included in the S&P 500 index

Is Ekso Bionics Holdings in the NASDAQ 100?

No, Ekso Bionics Holdings is not included in the NASDAQ 100 index

Is Ekso Bionics Holdings in the Dow Jones?

No, Ekso Bionics Holdings is not included in the Dow Jones index

When was Ekso Bionics Holdings's last earnings report?

Ekso Bionics Holdings's most recent earnings report was on 28 October 2024

When does Ekso Bionics Holdings report earnings?

The next expected earnings date for Ekso Bionics Holdings is 4 March 2025

Should I buy Ekso Bionics Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions